- Home
- CORT vs BRKR Comparison
CORT vs BRKR Comparison
Compare CORT & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- BRKR
- Stock Information
- Founded
- CORT 1998
- BRKR 1960
- Country
- CORT United States
- BRKR United States
- Employees
- CORT N/A
- BRKR N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- CORT Health Care
- BRKR Industrials
- Exchange
- CORT Nasdaq
- BRKR Nasdaq
- Market Cap
- CORT 7.6B
- BRKR 7.2B
- IPO Year
- CORT N/A
- BRKR 2000
- Fundamental
- Price
- CORT $80.94
- BRKR $49.60
- Analyst Decision
- CORT Strong Buy
- BRKR Buy
- Analyst Count
- CORT 5
- BRKR 10
- Target Price
- CORT $139.00
- BRKR $45.67
- AVG Volume (30 Days)
- CORT 639.6K
- BRKR 2.9M
- Earning Date
- CORT 11-04-2025
- BRKR 11-03-2025
- Dividend Yield
- CORT N/A
- BRKR 0.41%
- EPS Growth
- CORT N/A
- BRKR N/A
- EPS
- CORT 0.87
- BRKR N/A
- Revenue
- CORT $741,172,000.00
- BRKR $3,438,900,000.00
- Revenue This Year
- CORT $28.85
- BRKR $4.27
- Revenue Next Year
- CORT $34.98
- BRKR $1.34
- P/E Ratio
- CORT $91.92
- BRKR N/A
- Revenue Growth
- CORT 17.92
- BRKR 6.10
- 52 Week Low
- CORT $49.00
- BRKR $28.53
- 52 Week High
- CORT $117.33
- BRKR $64.64
- Technical
- Relative Strength Index (RSI)
- CORT 61.15
- BRKR 82.16
- Support Level
- CORT $73.79
- BRKR $40.64
- Resistance Level
- CORT $78.99
- BRKR $43.37
- Average True Range (ATR)
- CORT 3.03
- BRKR 1.77
- MACD
- CORT 0.61
- BRKR 0.68
- Stochastic Oscillator
- CORT 95.41
- BRKR 100.00
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.